Pre to Post-Treatment Glioblastoma MRI Prediction using a Latent Diffusion Model

• URL: http://arxiv.org/abs/2510.17851v1
• Date: Mon, 13 Oct 2025 20:32:06 GMT
• Title: Pre to Post-Treatment Glioblastoma MRI Prediction using a Latent Diffusion Model
• Authors: Alexandre G. Leclercq, Sébastien Bougleux, Noémie N. Moreau, Alexis Desmonts, Romain Hérault, Aurélien Corroyer-Dulmont,
• Abstract summary: We propose a Latent Diffusion Model with a concatenation-based conditioning from the pre-treatment MRI and the tumor localization.<n>Our model were trained and tested on a local dataset consisting of 140 GBM patients collected at Centre Franccois Baclesse.
• Score: 35.86812994963753
• License: http://creativecommons.org/licenses/by-sa/4.0/
• Abstract: Glioblastoma (GBM) is an aggressive primary brain tumor with a median survival of approximately 15 months. In clinical practice, the Stupp protocol serves as the standard first-line treatment. However, patients exhibit highly heterogeneous therapeutic responses which required at least two months before first visual impact can be observed, typically with MRI. Early prediction treatment response is crucial for advancing personalized medicine. Disease Progression Modeling (DPM) aims to capture the trajectory of disease evolution, while Treatment Response Prediction (TRP) focuses on assessing the impact of therapeutic interventions. Whereas most TRP approaches primarly rely on timeseries data, we consider the problem of early visual TRP as a slice-to-slice translation model generating post-treatment MRI from a pre-treatment MRI, thus reflecting the tumor evolution. To address this problem we propose a Latent Diffusion Model with a concatenation-based conditioning from the pre-treatment MRI and the tumor localization, and a classifier-free guidance to enhance generation quality using survival information, in particular post-treatment tumor evolution. Our model were trained and tested on a local dataset consisting of 140 GBM patients collected at Centre Fran\c{c}ois Baclesse. For each patient we collected pre and post T1-Gd MRI, tumor localization manually delineated in the pre-treatment MRI by medical experts, and survival information.

Related papers

• CLARITY: Medical World Model for Guiding Treatment Decisions by Modeling Context-Aware Disease Trajectories in Latent Space [49.74032713886216]
  CLARITY is a medical world model that forecasts disease evolution directly within a structured latent space.<n>It explicitly integrates time intervals (temporal context) and patient-specific data (clinical context) to model treatment-conditioned progression as a smooth, interpretable trajectory.
  arXiv  Detail & Related papers  (2025-12-08T20:42:10Z)
• Medical World Model: Generative Simulation of Tumor Evolution for Treatment Planning [50.16114813279694]
  We introduce the Medical World Model (MeWM), the first world model in medicine that visually predicts future disease states based on clinical decisions.<n>MeWM comprises (i) vision-language models to serve as policy models, and (ii) tumor generative models as dynamics models.<n>We propose the inverse dynamics model that applies survival analysis to the simulated post-treatment tumor, enabling the evaluation of treatment efficacy and the selection of the optimal clinical action plan.
  arXiv  Detail & Related papers  (2025-06-02T23:50:40Z)
• ContextMRI: Enhancing Compressed Sensing MRI through Metadata Conditioning [51.26601171361753]
  We propose ContextMRI, a text-conditioned diffusion model for MRI that integrates granular metadata into the reconstruction process.<n>We show that increasing the fidelity of metadata, ranging from slice location and contrast to patient age, sex, and pathology, systematically boosts reconstruction performance.
  arXiv  Detail & Related papers  (2025-01-08T05:15:43Z)
• Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction [71.91773485443125]
  Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer. The current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts. This research investigates the application of optimized CDI$s$ to enhance breast cancer pathologic complete response prediction.
  arXiv  Detail & Related papers  (2024-05-13T15:40:56Z)
• Treatment-wise Glioblastoma Survival Inference with Multi-parametric Preoperative MRI [34.830878479276286]
  We propose a treatment-conditioned regression model for glioblastoma ST that incorporates treatment information in addition to MR scans. Our approach allows us to effectively utilize the data from all of the treatments in a unified manner, rather than having to train separate models for each of the treatments.
  arXiv  Detail & Related papers  (2024-02-10T16:13:09Z)
• Treatment-aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction [0.5667953366862138]
  We present a novel end-to-end network capable of future predictions of tumor masks and multi-parametric magnetic resonance images (MRI) of how the tumor will look at any future time points for different treatment plans.<n>Our approach is based on cutting-edge diffusion probabilistic models and deep-segmentation neural networks.
  arXiv  Detail & Related papers  (2023-09-11T12:12:52Z)
• Domain Transfer Through Image-to-Image Translation for Uncertainty-Aware Prostate Cancer Classification [42.75911994044675]
  We present a novel approach for unpaired image-to-image translation of prostate MRIs and an uncertainty-aware training approach for classifying clinically significant PCa. Our approach involves a novel pipeline for translating unpaired 3.0T multi-parametric prostate MRIs to 1.5T, thereby augmenting the available training data. Our experiments demonstrate that the proposed method significantly improves the Area Under ROC Curve (AUC) by over 20% compared to the previous work.
  arXiv  Detail & Related papers  (2023-07-02T05:26:54Z)
• The Rio Hortega University Hospital Glioblastoma dataset: a comprehensive collection of preoperative, early postoperative and recurrence MRI scans (RHUH-GBM) [0.0]
  "R'io Hortega University Hospital Glioblastoma dataset" is a collection of multiparametric MRI images, volumetric assessments, molecular data, and survival details. The dataset features expert-corrected segmentations of tumor subregions, offering valuable ground truth data for developing algorithms for postoperative and follow-up MRI scans.
  arXiv  Detail & Related papers  (2023-04-27T13:10:55Z)
• Enhancing Clinical Support for Breast Cancer with Deep Learning Models using Synthetic Correlated Diffusion Imaging [66.63200823918429]
  We investigate enhancing clinical support for breast cancer with deep learning models. We leverage a volumetric convolutional neural network to learn deep radiomic features from a pre-treatment cohort. We find that the proposed approach can achieve better performance for both grade and post-treatment response prediction.
  arXiv  Detail & Related papers  (2022-11-10T03:02:12Z)
• Recurrence-free Survival Prediction under the Guidance of Automatic Gross Tumor Volume Segmentation for Head and Neck Cancers [8.598790229614071]
  We developed an automated primary tumor (GTVp) and lymph nodes (GTVn) segmentation method. We extracted radiomics features from the segmented tumor volume and constructed a multi-modality tumor recurrence-free survival (RFS) prediction model.
  arXiv  Detail & Related papers  (2022-09-22T18:44:57Z)
• PD-DWI: Predicting response to neoadjuvant chemotherapy in invasive breast cancer with Physiologically-Decomposed Diffusion-Weighted MRI machine-learning model [0.0]
  We introduce PD-DWI, a physiologically decomposed DWI machine-learning model to predict pCR from DWI and clinical data. Our model substantially improves the area under the curve (AUC), compared to the current best result on the leaderboard.
  arXiv  Detail & Related papers  (2022-06-12T08:59:49Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.